Login
Home / 069620.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Daewoong pharmaceutical Co.,Ltd

₩109800 -$56200.00 (-33.86%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩111100
Day Range
₩109500₩112000
Year Range
₩105000₩199400
Market Cap
1.26T
AVG Volume
37.77K
Trailing/Forward PE
6.46/6.99
PEG ratio
-0.91
Dividend Yield
0.55%
Next Earnings Date
2026-11-12
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0200B400B600B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
020B40B60B80B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
025B50B75B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-60B-40B-20B020B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-250002500500075001000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
0100B200B300BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
0250B500B750B1TCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-2.5%0%2.5%5%7.5%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0200400600800Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Book Value Per Share (KRW)
05000010000015000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
01T2T3T24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
020406080med 20.21Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-12.5%-10%-7.5%-5%-2.5%med -7.55%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.60.811.21.41.6med 1.08Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
7.51012.51517.5med 12.34Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
0204060med 17.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
11.522.5med 1.64Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Daewoong pharmaceutical Co.,Ltd
069620.KS
Stockpicker

Video analysis: 069620.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.